Bordetella Pertussis Flashcards
Bordetella Pertussis: Detailed Overview
Introduction to Bordetella
- Bordetella is a family of microorganisms that causes disease in both humans and animals.
- The most important organism in this family is Bordetella pertussis, which causes whooping cough (pertussis).
- Parapertussis, a cousin of Bordetella pertussis, causes a milder infection compared to pertussis, similar to how parainfluenza relates to influenza.
- In severe cases, pertussis predominantly affects the bronchioles, posing a significant risk of death to young infants due to necrosis in the bronchioles.
- In adults, pertussis typically presents as laryngitis or bronchitis, leading to a chronic nagging cough.
Characteristics and Identification
- On Gram stain, Bordetella appears as a coccobacillus, potentially more coccoid than Haemophilus.
- It is a slow-growing organism, often outgrown by other respiratory organisms on standard HBA and chocolate agar plates.
- Selective media is required to culture Bordetella, with growth taking around five days.
- Due to the slow growth, many labs do not attempt to culture the organism, which is detrimental for studying changes in the organism and potential vaccine escape.
- Cultures of Bordetella pertussis on Bordet-Gengou medium show raised, pearly-looking colonies described as "bisected pearls."
Epidemiology and Transmission
- Bordetella pertussis is highly infectious and spreads quickly through communities, especially with poor vaccination coverage.
- It is purely a human-carried organism.
- Infectiousness is highest during the catarrhal stage.
- Secondary attack rates are high, indicating a significant risk of transmission to individuals in close proximity to infected persons.
- Children under two months of age are at the greatest risk of death from pertussis.
Pathogenesis
- Bordetella pertussis effectively destroys ciliated cells through various mechanisms.
- Destruction of cilia impairs mucus clearance, allowing the organism to grow and kill cells.
- The organism modulates the host immune response, utilizing factors like surfactant A (SPA) and lipo-oligosaccharide (LOS).
- LOS inhibits complement and is not recognized by surfactant A, which normally controls respiratory infections.
- The organism can survive within phagocytes, limiting the effectiveness of phagocytosis.
- Pertussis suppresses lymphocyte-derived immunity and antibody production, leading to poor long-term immunity.
- In young children, damage extends to the bronchioles, where necrosis leads to plugs of necrotic material that interfere with oxygen exchange, often requiring hospitalization.
Key Virulence Factors
- Filamentous Hemagglutinin (FHA):
- Agglutinates erythrocytes when separated.
- Important for adhesion and initiating invasion.
- Fimbriae:
- Small, hair-like appendages on the surface of bacteria.
- Important for adhesion.
- Pertactin:
- Important for cell wall adhesion.
- Assists in invasion.
- Adenylate Cyclase Toxin:
- Interferes with internal cytoplasmic processes, slowing down cellular functions.
- Impairs leukocyte function.
- Tracheal Cytotoxin and BTEA:
- Toxins that damage ciliated epithelial cells.
- BTEA:
- Injected through a type three secretion system (think of needles injecting effector proteins).
- Pertussis Toxin (PT):
- Not found in parapertussis, potentially explaining milder infections.
- An AB toxin with a binding (B) part consisting of a pentamer (five parts).
Visual Representation of Pathogenesis
- The organism attaches to cells via filamentous hemagglutinin and other surface proteins.
- It injects toxins (like BTEA) using a type three secretion system.
- Pertussis toxin is excreted, with the binding part (pentamer) facilitating entry and causing cellular damage.
- Overall process leads to ciliary damage, reactive oxygen species production, cellular death, and cyanotoxicity.
Diagnosis
- PCR is now the primary method for pertussis identification, according to the CDC.
- Serological diagnosis was previously emphasized, but pertussis is effective at suppressing antibody production, resulting in poor IgG production.
- Nasopharyngeal specimens for culture must be collected within the first two weeks of coughing.
Treatment
- Early treatment is more effective.
- Adults with chronic coughs are typically not treated.
- Infants and young children are treated with azithromycin or erythromycin.
- Penicillin is not effective against Bordetella.
- Prophylaxis is given to household contacts, especially when infants are at risk.
Vaccination
- Vaccination is the most important means of preventing pertussis.
- Falling vaccination rates, often due to anti-vaccination messaging, result in infants being hospitalized.
- Vaccine protection lasts approximately five years, necessitating revaccination, especially for individuals in households with new babies.
- The current acellular vaccine is an improvement over previous vaccines, minimizing side effects and encouraging vaccination.
- Understanding and promoting childhood vaccination schedules is crucial for microbiologists.